A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective
Abstract Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of etiologies. The disease can eventually lead to irreversible damage to the lung tissue structure, severely affecting respiratory function and posing a serious threat to human health. Currently, gluco...
Saved in:
Main Authors: | Shanbo Qin (Author), Peng Tan (Author), Junjie Xie (Author), Yongfeng Zhou (Author), Junning Zhao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
by: Chunzhen Ren, et al.
Published: (2022) -
Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models
by: Yong Xu, et al.
Published: (2021) -
Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
by: Wen-Qing Li, et al.
Published: (2022) -
Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
by: Jiansheng Li, et al.
Published: (2022) -
Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury
by: Hong Yang Zhang, et al.
Published: (2018)